Our analysis also revealed significantly elevated ACE2 levels, among ACE2-positive AT2 and cells of the malignant-enriched cluster, in patients who were on hypertension treatment with losartan compared to those without antihypertensive therapy. This evidence concerns the gene ACE2 and hypertensive disorder.